Mal di testa, terapia d’elezione: la bibliografia
di Matteo Alberto Baio, ricercatore SIFAC
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9): 629-808. [PMID: 23771276]
- Stovner L et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3): 193-210. [PMID: 17381554]
- Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 386(9995): 743-800. [PMID: 26063472]
- Sarchielli P et al. Italian guidelines for primary headaches: 2012 revised version. J Headache Pain. 2012; 13 Suppl 2: S31-70. [PMID: 22581120]
- Martìnez-Martìn P et al. Efficacy and safety of metamizol vs. acetylsalicylic acid in patients with moderate episodic tension-type headache: a randomized, double-blind, placebo and active-controlled, multicentre study. Cephalalgia 2001; 21: 604-10. [PMID: 11472387]
- Diener HC et al. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 2004; 24(11): 947-54. [PMID: 15482357]
- Diener HC et al. Efficacy of 1,000mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur Neurol 2004; 52: 50-6. [PMID: 15240983]
- Lanas A et al. Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds – gastrointestinal adverse effects: a meta-analysis of randomized clinical trials. Drugs R D 2011; 11: 277‐88. [PMID: 21902288]
- Lecchi M et al. Pharmacokinetics and safety of a new aspirin formulation for the acute treatment of primary headaches. Expert Opin Drug Metab Toxicol. 2014; 10(10): 1381-95. [PMID: 25219631]
